Decision Resources Group, a subsidiary of Piramal Enterprises Ltd. announced on 4th December its acquisition of Abacus International, a UK based provider of evidence-based global market access solutions for many healthcare companies worldwide. Abacus will become part of the Market Access Business Unit at Decision Resources Group which currently includes the brands: Fingertip Formulary, HealthLeaders-InterStudy, PharmaStrat and Pinsonault. The terms of the deal were not disclosed.
Founded in 1995, Abacus has experience “across a wide range of disease areas,” providing services to its healthcare (many of which pharmaceutical) clients at all stages of their product life cycles including analysis of clinical evidence, development of technical health economic models and pricing input amongst others. With over 55 staff, Abacus is one of the largest independent health economic consultancies in Europe. The firm also offers software solutions in the form of in-house produced web and mobile applications.
Abacus states on its website that its current management team will remain in place and that it will “continue to deliver its services as normal.” The firm will also remain headquartered in Bicester, UK.
Peter Hoenigsberg, CEO of Decision Resources Group said “Abacus is an important acquisition in Decision Resources Group’s overall strategy to expand our market access capabilities and offer our clients the most innovative, high-value advisory solutions.” He continued “It also serves to boost our position in Europe as an important resource for healthcare firms worldwide.” The firm’s press release for the acquisition states that “The acquisition is part of Decision Resources Group’s overall strategy to acquire and/or build leading brands that can leverage each other’s thought leadership to create meaningful products and services for the healthcare industry.” View the press release here.
US, Massachusetts & UK, Bicester
- Decision Resources Group Acquires Pinsonault Posted on April 17, 2012